Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-11 Purchase |
2021-05-12 4:28 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
2,500 | $10.96 | $27,389 | 3,700 (Direct) |
View |
| 2021-05-11 Purchase |
2021-05-11 4:53 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
1,000 | $9.74 | $9,740 | 1,000 (Direct) |
View |
| 2021-03-12 Sale |
2021-03-15 4:36 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
40,000 | $13.49 | $539,600 | 187,299 (Direct) |
View |
| 2021-03-05 Purchase |
2021-03-09 4:25 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
5,000 | $13 | $65,000 | 45,000 (Direct) |
View |
| 2021-01-29 Purchase |
2021-02-02 3:22 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
1,600 | $16.03 | $25,648 | 2,600 (Indirect Direct) |
View |
| 2021-01-28 Purchase |
2021-01-29 12:24 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
900 | $16.14 | $14,526 | 2,720 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-11 Exercise |
2021-05-12 4:30 pm |
N/A 2021-03-30 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
20,000 | $0 | 221,861 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-12 4:30 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
20,000 | $3.02 | 221,861 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-11 5:22 pm |
N/A 2021-03-30 |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research |
40,000 | $0 | 143,592 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-11 5:22 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research |
40,000 | $3.02 | 143,592 (Direct) |
View |
| 2021-03-12 Exercise |
2021-03-15 4:36 pm |
N/A 2021-03-30 |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
40,000 | $0 | 187,299 (Direct) |
View |
| 2021-03-12 Exercise |
2021-03-15 4:36 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
40,000 | $3.02 | 187,299 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 3:18 pm |
N/A 2028-02-22 |
Aurinia Pharmaceuticals Inc. | AUPH | Hayden Michael R Director |
95,000 | $0 | 95,000 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 3:18 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hayden Michael R Director |
50,000 | $5.44 | 95,000 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 3:18 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hayden Michael R Director |
30,000 | $6.06 | 95,000 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-02 3:18 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hayden Michael R Director |
15,000 | $6.42 | 95,000 (Direct) |
View |
Ownership |
2021-01-04 6:12 pm |
N/A 2030-04-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Walbert Timothy P Director |
0 | $0 | 80,000 (Direct) |
View |
Ownership |
2021-01-04 6:11 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
0 | $0 | 918,383 (Direct) |
View |
Ownership |
2021-01-04 6:09 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
0 | $0 | 445,228 (Direct) |
View |
Ownership |
2021-01-04 6:08 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
0 | $0 | 205,000 (Direct) |
View |
Ownership |
2021-01-04 6:07 pm |
N/A 2030-04-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
0 | $0 | 453,050 (Direct) |
View |
Ownership |
2021-01-04 6:05 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
0 | $0 | 681,386 (Direct) |
View |
Ownership |
2021-01-04 6:04 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
0 | $0 | 81,500 (Direct) |
View |
Ownership |
2021-01-04 6:03 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
0 | $0 | 81,000 (Direct) |
View |
Ownership |
2021-01-04 6:01 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
0 | $0 | 165,000 (Direct) |
View |
Ownership |
2021-01-04 5:58 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research |
0 | $0 | 719,285 (Direct) |
View |
Ownership |
2021-01-04 5:57 pm |
N/A 2028-02-22 |
Aurinia Pharmaceuticals Inc. | AUPH | Hayden Michael R Director |
0 | $0 | 125,000 (Direct) |
View |
Ownership |
2021-01-04 5:56 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
0 | $0 | 128,500 (Direct) |
View |
Ownership |
2021-01-04 5:53 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
0 | $0 | 2,838,128 (Direct) |
View |
Ownership |
2021-01-04 5:48 pm |
N/A 2029-08-19 |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
0 | $0 | 613,452 (Direct) |
View |
Ownership |
2021-01-04 5:45 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Colao Massimilano Chief Commercial Officer |
0 | $0 | 680,837 (Direct) |
View |
Ownership |
2021-01-04 5:44 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
0 | $0 | 115,000 (Direct) |
View |